ABBV — AbbVie Inc.
—
NYSE ·
Health Care ·
Pharmaceuticals ·
CIK 1551152 ·
Last close
$253.35
Market Cap
$447.62B
52W High
$253.35
52W Low
$190.75
ADV30
7,485,027
Next earnings
2026-07-31
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | — | — | — | — | — | — | — |
| Dec 2025 | 16,618,000,000 | 12,066,000,000 | 5,809,000,000 | 1,816,000,000 | 133,960,000,000 | 5,229,000,000 | 137,188,000,000 |
| Sep 2025 | 15,776,000,000 | 10,472,000,000 | 4,584,000,000 | 186,000,000 | 133,898,000,000 | 5,629,000,000 | 136,497,000,000 |
| Jun 2025 | 15,423,000,000 | 11,077,000,000 | 5,717,000,000 | 938,000,000 | 137,182,000,000 | 6,467,000,000 | 137,320,000,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$19,030,000,000
Investing CF
$-6,643,000,000
Financing CF
$-12,724,000,000
CapEx
$-1,214,000,000
Dividends Paid
$-11,657,000,000
Buybacks
$-980,000,000
EPS Diluted TTM
$2.03
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-15,493,000,000
Inventory
$4,951,000,000
Receivables
$12,589,000,000
ST Investments
$28,000,000
EBIT TTM
$7,129,000,000
Pretax Income TTM
$4,936,000,000
Interest Exp TTM
$2,193,000,000
Analysts
30
Yahoo Snapshot (yfinance, live)
Total Revenue
$62,819,000,320
EBITDA
$29,915,000,832
Free Cash Flow
$20,811,624,448
Enterprise Value
$511,181,946,880
Total Cash
$9,390,999,552
Total Debt
$72,912,003,072
Shares Out
1,766,792,821
Trailing EPS
$2.05
Book Value
$-3.77
ROE
—
ROA
10.0%
Div Yield
2.73%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 61,160,000,000 | 20,091,000,000 | 4,226,000,000 | 133,960,000,000 | 137,188,000,000 | — | 19,030,000,000 |
| Dec 2024 | 56,334,000,000 | 11,894,000,000 | 4,278,000,000 | 135,161,000,000 | 131,797,000,000 | — | 18,806,000,000 |
| Dec 2023 | 54,318,000,000 | 13,535,000,000 | 4,863,000,000 | 134,711,000,000 | 124,314,000,000 | — | 22,839,000,000 |
| Dec 2022 | 58,054,000,000 | 18,814,000,000 | 11,836,000,000 | 138,805,000,000 | 121,518,000,000 | — | 24,943,000,000 |
TTM Snapshot
Revenues TTM
$57,541,000,000
NetIncome TTM
$10,467,000,000
OpCashFlow TTM
$0
Assets (Latest)
$135,161,000,000
Forward EPS
$16.29
Max Pain — expiry 2026-07-02
max pain strike: $227.50 · spot: $254.77 · call oi: 6,399 · put oi: 2,702
Expected Move to 2026-07-02:
±$6.09
(2.39%) —
implied range
$248.68 –
$260.87
· ATM straddle on $255.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| JNJ | JOHNSON & JOHNSON | $613.02B | $254.66 | — |
| MRK | Merck & Co., Inc. | $317.77B | $128.66 | — |
| NVS | NOVARTIS AG | $296.54B | $155.41 | — |
| NVSEF | NOVARTIS AG | $292.66B | $153.38 | — |
| AZN | ASTRAZENECA PLC | $292.20B | $188.41 | — |
News headlines (Yahoo Finance, 1h cache)
AbbVie Stock Hits a New 52-Week High. Has It Gotten Too Expensive to Buy?
2026-06-29 15:41 · Yahoo
AbbVie (ABBV) Moves 4.2% Higher: Will This Strength Last?
2026-06-29 14:19 · Yahoo
2 S&P 500 Stocks with Promising Prospects and 1 We Find Risky
2026-06-29 14:02 · Yahoo
Here's Why Shares of Eli Lilly Hit an All-Time High on Friday
2026-06-29 13:27 · Yahoo
REGENXBIO Announces First Patient Dosed in Phase IIb/III NAAVIGATE Trial of Surabgene Lomparvovec in Diabetic Retinopathy; Company to Receive $100 Million Milestone
2026-06-29 11:05 · Yahoo
AbbVie Receives Positive CHMP Opinion for Upadacitinib (RINVOQ®) for the Treatment of Adults and Adolescents with Severe Alopecia Areata
2026-06-29 07:10 · Yahoo
AbbVie Receives Positive CHMP Opinion for Upadacitinib (RINVOQ®) for the Treatment of Adults and Adolescents with Non-segmental Vitiligo
2026-06-29 07:00 · Yahoo
RBC Capital Maintains a Sector Perform Rating on Regeneron (REGN) – Here’s Why
2026-06-28 14:01 · Yahoo
AbbVie (ABBV) Wins Health Canada Approval for Boey
2026-06-28 00:07 · Yahoo
AbbVie (ABBV) to Acquire Apogee Therapeutics
2026-06-27 19:21 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.